Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Panyapat Jiampo"'
Autor:
Thanita Boonyapiphat, Thidaporn Tangkittikasem, Artit Torpongpun, Vichai Senthong, Panyapat Jiampo
Publikováno v:
Cardiology and Therapy, Vol 13, Iss 2, Pp 415-430 (2024)
Abstract Introduction There are limited data on the burden of newly diagnosed patients with heart failure (HF) in Thailand. Thus, this study aimed to fully understand the hospitalization, rehospitalization, mortality rates, demographics and character
Externí odkaz:
https://doaj.org/article/45045770c2c64b37be67c0b6f6cf53f8
Autor:
Panyapat Jiampo, Thidaporn Tangkittikasem, Thanita Boonyapiphat, Vichai Senthong, Artit Torpongpun
Publikováno v:
Cardiology and Therapy, Vol 13, Iss 2, Pp 281-297 (2024)
Abstract Introduction Heart failure (HF) is one of the leading causes of hospitalization worldwide. In Thailand, data on HF burden remains limited. This study aimed to describe comprehensive evidence detailing the HF prevalence, hospital admission ra
Externí odkaz:
https://doaj.org/article/365c292fc0a74068abcc2c4f4043a388
Autor:
Eue-Keun Choi, Young-Soo Lee, Alan Koay Choon Chern, Panyapat Jiampo, Aurauma Chutinet, Dicky Armein Hanafy, Prabhav Trivedi, Dongmei Zhai, Yong Seog Oh
Publikováno v:
Open Heart, Vol 8, Iss 2 (2021)
Purpose Dabigatran is a direct thrombin inhibitor approved for stroke prophylaxis in patients with non-valvular atrial fibrillation (NVAF). Real-world data about patient preference, satisfaction and convenience in patients in Asia are not available.
Externí odkaz:
https://doaj.org/article/0af16d858c9344099d0c83d1665c5850
Autor:
Eue-Keun Choi, Young-Soo Lee, Alan Koay Choon Chern, Panyapat Jiampo, Aurauma Chutinet, Dicky Armein Hanafy, Prabhav Trivedi, Dongmei Zhai, Yong Seog Oh
Publikováno v:
Open Heart, Vol 7, Iss 2 (2020)
Background and purpose Real-world data about treatment convenience and satisfaction in Asian non-valvular atrial fibrillation (NVAF) patients after switching from vitamin K antagonists (VKAs) to non-VKA oral anticoagulants were evaluated.Methods In t
Externí odkaz:
https://doaj.org/article/75aed3edfa014132b463fa61793e5e20
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Dicky A. Hanafy, Prabhav Trivedi, Yong Seog Oh, Aurauma Chutinet, Panyapat Jiampo, Dongmei Zhai, Young-Soo Lee, Eue Keun Choi, Alan Koay Choon Chern
Publikováno v:
Open Heart, Vol 8, Iss 2 (2021)
Open Heart
Open Heart
PurposeDabigatran is a direct thrombin inhibitor approved for stroke prophylaxis in patients with non-valvular atrial fibrillation (NVAF). Real-world data about patient preference, satisfaction and convenience in patients in Asia are not available. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a42d9b96082f76d385a86226a3713d01
https://openheart.bmj.com/content/8/2/e001745.full
https://openheart.bmj.com/content/8/2/e001745.full
Publikováno v:
Journal of the Medical Association of Thailand; Sep2022, Vol. 105 Issue 9, p872-875, 4p
Autor:
Panyapat Jiampo, Dicky A. Hanafy, Prabhav Trivedi, Yong Seog Oh, Alan Koay Choon Chern, Young Soo Lee, Dongmei Zhai, Eue Keun Choi, Aurauma Chutinet
Publikováno v:
Open Heart, Vol 7, Iss 2 (2020)
Open Heart
Open Heart
Background and purposeReal-world data about treatment convenience and satisfaction in Asian non-valvular atrial fibrillation (NVAF) patients after switching from vitamin K antagonists (VKAs) to non-VKA oral anticoagulants were evaluated.MethodsIn thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38e2945f713db2592e12bc486db3e2e0
https://openheart.bmj.com/content/7/2/e001343.full
https://openheart.bmj.com/content/7/2/e001343.full